Previous close | 177.61 |
Open | 179.15 |
Bid | 0.00 x 800 |
Ask | 0.00 x 1000 |
Day's range | 176.92 - 179.42 |
52-week range | 132.24 - 243.52 |
Volume | |
Avg. volume | 1,046,104 |
Market cap | 26.301B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | 29.60 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.92 (1.08%) |
Ex-dividend date | 07 Feb 2024 |
1y target est | N/A |
ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, RMD, ZBH, PODD and LNTH are well-poised to gain from the favorable factors.
Key Insights Given the large stake in the stock by institutions, ResMed's stock price might be vulnerable to their...